Loading...
HCA Healthcare, Inc.
HCA•NYSE
Healthcare
Medical - Care Facilities
$334.32
$-7.16(-2.10%)
HCA Healthcare, Inc. (HCA) Financial Performance & Income Statement Overview
Review HCA Healthcare, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
8.67%
↑ 8.67%
Operating Income Growth
9.56%
↑ 9.56%
Net Income Growth
9.88%
↑ 9.88%
Operating Cash Flow Growth
11.48%
↑ 11.48%
Operating Margin
11.16%
↑ 11.16%
Gross Margin
53.57%
↑ 53.57%
Net Profit Margin
5.95%
↑ 5.95%
ROE
-210.97%
↓ 210.97%
ROIC
10.49%
↑ 10.49%
HCA Healthcare, Inc. (HCA) Income Statement & Financial Overview
Review HCA Healthcare, Inc.'s (HCA) income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $18.32B | $18.29B | $17.49B | $17.49B |
| Cost of Revenue | $2.76B | $2.79B | $2.66B | $14.76B |
| Gross Profit | $15.56B | $15.49B | $14.83B | $2.73B |
| Gross Profit Ratio | $0.85 | $0.85 | $0.85 | $0.16 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $8.00B | $7.92B | $7.86B | $7.68B |
| Operating Expenses | $12.70B | $12.65B | $14.83B | $15.37B |
| Total Costs & Expenses | $15.47B | $10.71B | $15.08B | $14.76B |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $547.00M | $528.00M | $515.00M | $506.00M |
| Depreciation & Amortization | $860.00M | $856.00M | $842.00M | $819.00M |
| EBITDA | $3.73B | $3.52B | $3.26B | $3.55B |
| EBITDA Ratio | $0.20 | $0.19 | $0.19 | $0.20 |
| Operating Income | $2.85B | $2.85B | $2.41B | $2.73B |
| Operating Income Ratio | $0.16 | $0.16 | $0.14 | $0.16 |
| Other Income/Expenses (Net) | -$528.00M | -$713.00M | -$504.00M | -$494.00M |
| Income Before Tax | $2.33B | $2.13B | $1.91B | $2.24B |
| Income Before Tax Ratio | $0.13 | $0.12 | $0.11 | $0.13 |
| Income Tax Expense | $502.00M | $447.00M | $424.00M | $550.00M |
| Net Income | $1.61B | $1.44B | $1.27B | $1.46B |
| Net Income Ratio | $0.09 | $0.08 | $0.07 | $0.08 |
| EPS | $6.45 | $5.63 | $4.88 | $5.55 |
| Diluted EPS | $6.45 | $5.63 | $4.89 | $5.53 |
| Weighted Avg Shares Outstanding | $249.44M | $252.30M | $260.25M | $263.22M |
| Weighted Avg Shares Outstanding (Diluted) | $249.44M | $255.31M | $259.92M | $264.07M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan